Cargando…

A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma

Detalles Bibliográficos
Autores principales: Ladd, Alden, Lilley, Graham, Li, Mingli, Cossette, Dan, Hopkins, Gregory W, Maier, Dawn, Paglia, Michael, Morgan, Richard A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646118/
http://dx.doi.org/10.1186/2051-1426-3-S2-P117
_version_ 1782400918470262784
author Ladd, Alden
Lilley, Graham
Li, Mingli
Cossette, Dan
Hopkins, Gregory W
Maier, Dawn
Paglia, Michael
Morgan, Richard A
author_facet Ladd, Alden
Lilley, Graham
Li, Mingli
Cossette, Dan
Hopkins, Gregory W
Maier, Dawn
Paglia, Michael
Morgan, Richard A
author_sort Ladd, Alden
collection PubMed
description
format Online
Article
Text
id pubmed-4646118
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46461182015-11-20 A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma Ladd, Alden Lilley, Graham Li, Mingli Cossette, Dan Hopkins, Gregory W Maier, Dawn Paglia, Michael Morgan, Richard A J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646118/ http://dx.doi.org/10.1186/2051-1426-3-S2-P117 Text en Copyright © 2015 Ladd et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Ladd, Alden
Lilley, Graham
Li, Mingli
Cossette, Dan
Hopkins, Gregory W
Maier, Dawn
Paglia, Michael
Morgan, Richard A
A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma
title A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma
title_full A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma
title_fullStr A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma
title_full_unstemmed A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma
title_short A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma
title_sort simple and robust clinical manufacturing process for the ex-vivo expansion of autologous t cells genetically engineered to express an anti-bcma chimeric antigen receptor (car) for the treatment of multiple myeloma
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646118/
http://dx.doi.org/10.1186/2051-1426-3-S2-P117
work_keys_str_mv AT laddalden asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT lilleygraham asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT limingli asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT cossettedan asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT hopkinsgregoryw asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT maierdawn asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT pagliamichael asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT morganricharda asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT laddalden simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT lilleygraham simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT limingli simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT cossettedan simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT hopkinsgregoryw simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT maierdawn simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT pagliamichael simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma
AT morganricharda simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma